Yunling Du

4.0k total citations · 3 hit papers
43 papers, 2.9k citations indexed

About

Yunling Du is a scholar working on Surgery, Economics and Econometrics and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yunling Du has authored 43 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Surgery, 7 papers in Economics and Econometrics and 6 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yunling Du's work include Lipoproteins and Cardiovascular Health (13 papers), Retinopathy of Prematurity Studies (6 papers) and Pharmaceutical Economics and Policy (5 papers). Yunling Du is often cited by papers focused on Lipoproteins and Cardiovascular Health (13 papers), Retinopathy of Prematurity Studies (6 papers) and Pharmaceutical Economics and Policy (5 papers). Yunling Du collaborates with scholars based in United States, China and France. Yunling Du's co-authors include Stephan A. Mayer, E. Sander Connolly, Kurt T. Kreiter, Jan Claassen, Joseph E Bates, Gary L. Bernardini, Daphne Copeland, Evan A. Stein, Patricia W. Stone and Daniel A. Gipe and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Yunling Du

43 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Effect of Cisternal and Ventricular Blood on Risk of Delayed Cerebral Ischemia After Subarachnoid Hemorrhage:

2001 543 citations Yunling Du et al. profile →
Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol

2012 505 citations Evan A. Stein, Scott Mellis et al. New England Journal of Medicine profile →
Efficacy and safety of alirocumab vs ezetimibe in statin-intolerant patients, with a statin rechallenge arm: The ODYSSEY ALTERNATIVE randomized trial

2015 345 citations Patrick M. Moriarty, Paul D. Thompson et al. Journal of clinical lipidology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yunling Du United States	20	1.3k	697	517	271	263	43	2.9k
George F. Borm Netherlands	32	645 0.5×	449 0.6×	112 0.2×	154 0.6×	187 0.7×	62	3.5k
Jeanine E. Ransom United States	28	1.7k 1.3×	276 0.4×	139 0.3×	135 0.5×	366 1.4×	54	3.8k
Aaron Liew Ireland	30	642 0.5×	103 0.1×	504 1.0×	290 1.1×	288 1.1×	101	2.9k
Ching‐Chih Lee Taiwan	31	654 0.5×	317 0.5×	105 0.2×	120 0.4×	118 0.4×	136	2.7k
Robert I. Griffiths United States	26	321 0.2×	235 0.3×	228 0.4×	100 0.4×	143 0.5×	75	2.0k
James M. Schuster United States	31	1.4k 1.1×	612 0.9×	44 0.1×	161 0.6×	36 0.1×	168	3.4k
P. Kyzas United Kingdom	25	764 0.6×	180 0.3×	195 0.4×	100 0.4×	61 0.2×	54	2.9k
Thabele M Leslie‐Mazwi United States	32	636 0.5×	2.3k 3.3×	195 0.4×	233 0.9×	71 0.3×	169	6.7k
Lorenz Uhlmann Germany	23	346 0.3×	457 0.7×	112 0.2×	90 0.3×	50 0.2×	102	2.0k
Christopher J. Swearingen United States	28	450 0.3×	126 0.2×	101 0.2×	113 0.4×	150 0.6×	110	3.1k

Countries citing papers authored by Yunling Du

Since Specialization

Citations

This map shows the geographic impact of Yunling Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yunling Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yunling Du more than expected).

Fields of papers citing papers by Yunling Du

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yunling Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yunling Du. The network helps show where Yunling Du may publish in the future.

Co-authorship network of co-authors of Yunling Du

This figure shows the co-authorship network connecting the top 25 collaborators of Yunling Du. A scholar is included among the top collaborators of Yunling Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yunling Du. Yunling Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Du, Yunling, et al.. (2025). Effects of Energy Densities on Microstructure, Mechanical Properties, and Wear Behavior of Inconel 625 + Tungsten Carbide Coatings by Laser Cladding. steel research international. 1 indexed citations

Tan, Zihao, Xinguang Wang, Yunling Du, et al.. (2024). Failure-mode dependence on the formation of deformation twinning in the fourth-generation single crystal Ni-based superalloy at high temperatures. International Journal of Fatigue. 182. 108229–108229. 8 indexed citations

Zhang, Mengna, et al.. (2023). Two-sample Mendelian randomization study does not reveal a significant relationship between cytomegalovirus (CMV) infection and autism spectrum disorder. BMC Psychiatry. 23(1). 559–559. 5 indexed citations

Tan, Zihao, Xinguang Wang, Yongmei Li, et al.. (2023). Comprehensive damage and deformation mechanisms during out-of-phase thermal mechanical fatigue of the fourth-generation single crystal superalloy. International Journal of Fatigue. 178. 107990–107990. 9 indexed citations

Moriarty, Patrick M., Klaus G. Parhofer, Stephan P. Babirak, et al.. (2016). Alirocumab in patients with heterozygous familial hypercholesterolemia undergoing lipoprotein apheresis: Rationale and design of the ODYSSEY ESCAPE trial. Journal of clinical lipidology. 10(3). 627–634. 15 indexed citations

Moriarty, Patrick M., Klaus G. Parhofer, Stephan P. Babirak, et al.. (2016). Alirocumab in patients with heterozygous familial hypercholesterolaemia undergoing lipoprotein apheresis: the ODYSSEY ESCAPE trial. European Heart Journal. 37(48). 3588–3595. 135 indexed citations

Farnier, Michel, Peter J.H. Jones, Randall Severance, et al.. (2015). Efficacy and safety of adding alirocumab to rosuvastatin versus adding ezetimibe or doubling the rosuvastatin dose in high cardiovascular-risk patients: The ODYSSEY OPTIONS II randomized trial. Atherosclerosis. 244. 138–146. 160 indexed citations

Gaudet, Daniel, Dean J. Kereiakes, James M. McKenney, et al.. (2014). Effect of Alirocumab, a Monoclonal Proprotein Convertase Subtilisin/Kexin 9 Antibody, on Lipoprotein(a) Concentrations (a Pooled Analysis of 150 mg Every Two Weeks Dosing from Phase 2 Trials). The American Journal of Cardiology. 114(5). 711–715. 167 indexed citations

Stein, Evan A., Scott Mellis, George D. Yancopoulos, et al.. (2012). Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol. Obstetrical & Gynecological Survey. 67(7). 413–414. 10 indexed citations

10.

Dufour, Robert, Patrick M. Moriarty, Elisabeth Genestin, et al.. (2012). Abstract 16127: Effect of REGN727/SAR236553 Anti-Proprotein Convertase Subtilisin/Kexin Type 9 Fully Human Monoclonal Antibody in Patients with Elevated Triglycerides/Low High-Density Lipoprotein Cholesterol: Data from Three Phase 2 Studies (NCT:01266876; 01288469; 01288443). Circulation. 126. 2 indexed citations

11.

Gaudet, Daniel, Dean J. Kereiakes, Eli M. Roth, et al.. (2012). Abstract 14725: Effect of SAR236553/REGN727 Fully Human Monoclonal Anti-Proprotein Convertase Subtilisin/Kexin Type 9 Antibody on Plasma Lipoprotein(a) Concentrations: Pooled Analysis from Three Phase 2 Studies (NCT:01266876; 01288469; 01288443). Circulation. 126. 2 indexed citations

12.

Stein, Evan A., Scott Mellis, George D. Yancopoulos, et al.. (2012). Effect of a Monoclonal Antibody to PCSK9 on LDL Cholesterol. New England Journal of Medicine. 366(12). 1108–1118. 505 indexed citations breakdown →

13.

Swergold, Gary D., W. Smith, Scott Mellis, et al.. (2011). Abstract 16265: Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9 With a Monoclonal Antibody REGN727/SAR236553, Effectively Reduces Low-Density-Lipoprotein Cholesterol, as Mono or Add-on Therapy in Heterozygous Familial and Non Familial Hypercholesterolemia. Circulation. 124. 6 indexed citations

14.

Bruzzese, Jean‐Marie, Beverley J. Sheares, Yunling Du, et al.. (2010). Effects of a School-based Intervention for Urban Adolescents with Asthma: A Controlled Trial. American Journal of Respiratory and Critical Care Medicine. 183(8). 998–1006. 80 indexed citations

15.

Du, Yunling, et al.. (2009). Parental perceptions toward digital imaging and telemedicine for retinopathy of prematurity management. Graefe s Archive for Clinical and Experimental Ophthalmology. 248(1). 141–147. 15 indexed citations

16.

Gelman, Rony, et al.. (2007). Plus disease in retinopathy of prematurity: Pilot study of computer-based and expert diagnosis. Journal of American Association for Pediatric Ophthalmology and Strabismus. 11(6). 532–540. 76 indexed citations

17.

Stone, Patricia W., et al.. (2006). Comparison of Nurse, System and Quality Patient Care Outcomes in 8-Hour and 12-Hour Shifts. Medical Care. 44(12). 1099–1106. 78 indexed citations

18.

Ostfeld, Robert J., Michael Spinelli, Michael Schaefer, et al.. (2006). A Triglyceride/High‐Density Lipoprotein Ratio ≥3.5 Is Associated With an Increased Burden of Coronary Artery Disease on Cardiac Catheterization. PubMed. 1(1). 13–15. 14 indexed citations

19.

Choi, Jeungok, Suzanne Bakken, Elaine Larson, Yunling Du, & Patricia W. Stone. (2004). Perceived Nursing Work Environment of Critical Care Nurses. Nursing Research. 53(6). 370–378. 100 indexed citations

20.

Bruzzese, Jean‐Marie, Sebastian Bonner, Beverley J. Sheares, et al.. (2004). Asthma education: the adolescent experience. Patient Education and Counseling. 55(3). 396–406. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact